Clinical Trial Update: Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluated dehydroepiandrosterone (DHEA) supplementation for poor responders undergoing in vitro fertilization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: Meir Medical Center | Conditions: Ovarian Stimulation | NA | Status: COMPLETED